Uncategorized

After a bidding war erupted between Pfizer and Novo Nordisk over the fledgling obesity drug maker, Metsera decided to side with its original suitor.

This podcast explores how AI is transforming clinical care and reshaping how healthcare teams work.

The workforce reduction is part of a restructuring designed to improve accountability and accelerate growth and innovation.

  IMG   La postal nocturna de muchas ciudades parece triunfo perfecto: rascacielos encendidos, carteles brillantes, avenidas blancas como estadios. Sin embargo, detrás de ese brillo constante se esconde un enemigo silencioso pero muy concreto: la contaminación lum&iacute …

Under the model, set to start next year, the CMS will negotiate lower prices for Medicaid programs linked to those paid in select other countries.

Healthcare organizations should invest in after-attack recovery and carefully evaluate risks from vendors, according to industry experts who spoke at a Healthcare Dive virtual event.

During a press conference to announce a drug price deal for GLP-1s, President Donald Trump asked for more details about the ongoing bidding war between Novo Nordisk and Pfizer over obesity biotech Metsera.

The FDA previously placed two clinical studies on hold, including the Phase III trial in which the liver toxicity occurred. Intellia is working with experts to create a risk management program for nex-z.

The Phase III results impressed Guggenheim Partners analysts both in terms of efficacy and safety. If approved, atacicept would become the first APRIL/BAFF inhibitor for IgAN to make it to the market.

Following restricted vaccine approvals and changes to CDC immunization schedules, Merck, Pfizer, GSK and Sanofi are all suffering revenue hits to their vaccine programs.